...
首页> 外文期刊>British Journal of Haematology >Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort
【24h】

Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort

机译:所有小儿原发性血小板增多症是否都是骨髓增生性肿瘤?大型队列分析

获取原文
获取原文并翻译 | 示例
           

摘要

Sporadic essential thrombocythaemia (ET) is rare in paediatrics, and the diagnostic and clinical approach to paediatric cases cannot be simply copied from experience with adults. Here, we assessed 89 children with a clinical diagnosis of ET and found that 23 patients (258%) had a clonal disease. The JAK2 V617F mutation was identified in 14 children, 1 child had the MPL W515L mutation, and 6 had CALR mutations. The monoclonal X-chromosome inactivation pattern was seen in six patients (two with JAK2 V617F and two with CALR mutations). The other 66 patients (742%) had persistent thrombocytosis with no clonality. There were no clinical or haematological differences between the clonal and non-clonal patients. The relative proportion of ET-specific mutations in the clonal children was much the same as in adults. The higher prevalence of non-clonal cases suggests that some patients may not have myeloproliferative neoplasms, with significant implications for their treatment.
机译:散发性原发性血小板增多症(ET)在儿科患者中很少见,对儿科病例的诊断和临床方法不能简单地从成年人的经验中复制出来。在这里,我们评估了89例临床诊断为ET的儿童,发现23例(258%)患有克隆性疾病。在14名儿童中发现了JAK2 V617F突变,其中1名儿童具有MPL W515L突变,6名儿童具有CALR突变。在六名患者中发现了单克隆X染色体失活模式(两名患有JAK2 V617F,两名患有CALR突变)。其他66例患者(742%)患有持续性血小板增多症,无克隆性。克隆和非克隆患者之间没有临床或血液学差异。克隆儿童中ET特异性突变的相对比例与成人中的比例大致相同。非克隆病例的患病率较高表明某些患者可能没有骨髓增生性肿瘤,对其治疗具有重要意义。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号